Suchergebnisse - "Salazar, Ramon"

PubPharm (11)

1

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER) : a multicentre, open-label, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von Strickler, J. | Cercek, A. | Siena, S. | +84

2

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma : long term results

enthalten in: BMC cancer | 2020

von Salazar, R. | Capdevila, J. | Manzano, J. | +15

3

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors

enthalten in: The oncologist | 2018

von Salazar, R. | Garcia-Carbonero, R. | Libutti, S. | +16

4

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

5

Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial)

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Petty, R. | Anthoney, A. | Metges, J. | +10

6

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer : clinical and biological features

enthalten in: BMC cancer | 2015

von Salazar, R. | Capdevila, J. | Laquente, B. | +15

7

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8) : an open-label, randomised phase 3 trial

enthalten in: The Lancet. Oncology | 2014

von Taieb, J. | Tabernero, J. | Mini, E. | +116

CommentIn: Lancet Oncol. 2014 Jul;15(8):785-6. - PMID 24928084

8

Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer : the RESPECT trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Tabernero, J. | Garcia-Carbonero, R. | Cassidy, J. | +17

9

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT) : a phase 3 randomised controlled trial

enthalten in: The Lancet. Oncology | 2012

von de Gramont, A. | Van Cutsem, E. | Schmoll, H. | +17

CommentIn: Lancet Oncol. 2012 Dec;13(12):1176-7. - PMID 23168364

10

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer : a double-blind, randomized phase III study (HORIZON III)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Schmoll, H. | Cunningham, D. | Sobrero, A. | +12

CommentIn: Nat Rev Clin Oncol. 2012 Nov;9(11):609. - PMID 23044776